<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1108996</article-id><article-id pub-id-type="publisher-id">OALibJ-118742</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Knowledge Attitudes and Practices of Students Regarding the Vaccine against Covid-19. Case of Students Living on the University Campuses of the University of Lubumbashi
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Martin</surname><given-names>Banza Mwana Bute</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cathy</surname><given-names>Kahite Lugoma</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yannick</surname><given-names>Mutombo Mupanda</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Veddy</surname><given-names>Bonga Numba Watanga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mbuyu</surname><given-names>Umba Djino</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Placide</surname><given-names>Kangweji Mulaji</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Edmond</surname><given-names>Kalinde Nkomba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Umba</surname><given-names>Thierry Clément</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean-Luc</surname><given-names>Banze Lukanda</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fran&amp;ccedil;ois</surname><given-names>Lumbwe Yemba</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Francis</surname><given-names>Kalombo Umba</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Laurene</surname><given-names>Faida Amisa</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Christian</surname><given-names>Makali Ntamwenge</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Antoine</surname><given-names>Kasongo Nyandwe</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Néné</surname><given-names>Moma Kasongo</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Balthas</surname><given-names>Kabeya</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kabyla</surname><given-names>Ilunga Benjamin</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Simon</surname><given-names>Ilunga Kandolo</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jacques</surname><given-names>Camille Musolo Kwambamba</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib></contrib-group><aff id="aff9"><addr-line>National Social Security Fund, Katanga I Provincial Directorate, Lubumbashi, Democratic Republic of the Congo</addr-line></aff><aff id="aff2"><addr-line>Higher Institute of Higher Techniques of Kalemie, Kalemie, The Democratic Republic of the Congo</addr-line></aff><aff id="aff5"><addr-line>Department of Public Health, Faculty of Medicine, University of Lubumbashi, Occupational Medicine Research Unit, Lubumbashi, The Democratic Republic of the Congo</addr-line></aff><aff id="aff8"><addr-line>School of Public Health, University of Lubumbashi, Lubumbashi, The Democratic Republic of the Congo</addr-line></aff><aff id="aff7"><addr-line>Faculty of Medicine, University of Kolwezi, Kolwezi, The Democratic Republic of the Congo</addr-line></aff><aff id="aff6"><addr-line>Pediatrics Department, Sendwe Provincial Referral General Hospital, Lubumbashi, The Democratic Republic of the Congo</addr-line></aff><aff id="aff1"><addr-line>Higher Institute of Medical Techniques of Manono, Manono, The Democratic Republic of the Congo</addr-line></aff><aff id="aff4"><addr-line>National HIV/AIDS Control Program, Kolwezi, The Democratic Republic of the Congo</addr-line></aff><aff id="aff3"><addr-line>University of Manono, Manono, The Democratic Republic of the Congo</addr-line></aff><pub-date pub-type="epub"><day>30</day><month>06</month><year>2022</year></pub-date><volume>09</volume><issue>07</issue><fpage>1</fpage><lpage>10</lpage><history><date date-type="received"><day>14,</day>	<month>June</month>	<year>2022</year></date><date date-type="rev-recd"><day>23,</day>	<month>July</month>	<year>2022</year>	</date><date date-type="accepted"><day>26,</day>	<month>July</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: More than a year after its appearance, SARS-CoV-2 continues its global race. Scientists around the world are making rapid progress in developing safe and effective vaccines that will help reduce morbidity as well as mortality from COVID-19. Several vaccines have been developed and vaccination campaigns launched across the world, with hopes of controlling the pandemic. 
  Methodology: We conducted a descriptive study with an analytical aim to contribute to the fight against COVID-19 in the university residences of Lubumbashi. The data was encoded in Excel and exported to Epi info for analysis. 
  Results: Nearly six out of ten students agreed to be vaccinated. The refusal of the vaccine was motivated in 95.24% of cases by post-injection manifestations and in 4.76% of cases by lack of confidence in the vaccine. The post-injection manifestations as well as the confidence in the vaccine are the basis of the refusal to be vaccinated (P = 0.00). Confidence in the vaccine is influenced by post-injection manifestations (P = 0.00). In 66.8% of cases, students always observe barrier gestures, while 33.2% only respect them at their faculty or school. We have observed that nearly three (3) out of ten students consider COVID-19 to be bad luck 13.5% as one of the diseases of dirty hands. 
  Conclusion: This study provides key information related to medical student vaccination in Lubumbashi. In conclusion, we notice that the acceptability of the vaccine against COVID-19 constitutes a public health problem, which is why we recommend that health authorities be able to advocate for awareness and respect for barrier measures.
 
</p></abstract><kwd-group><kwd>COVID-19</kwd><kwd> Acceptability</kwd><kwd> Vaccine</kwd><kwd> University</kwd><kwd> Lubumbashi</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Coronaviruses (CoVs) are a group of related viruses that can cause respiratory tract infections in humans ranging from mild symptoms to lethal outcomes. Until now, there are seven genera of CoVs that are known to infect humans [<xref ref-type="bibr" rid="scirp.118742-ref2">2</xref>].</p><p>Vaccine hesitancy has been considered by the World Health Organization (WHO) as “one of the top-ten threats to global health” causing serious problems in achieving coverage for population immunity [<xref ref-type="bibr" rid="scirp.118742-ref3">3</xref>].</p><p>At the end of 2020, the new hope to counter the global pandemic―the COVID-19 vaccine―appeared. The first vaccines against COVID-19 were administered to the general public in Slovakia on 5 January [<xref ref-type="bibr" rid="scirp.118742-ref4">4</xref>].</p><p>The COVID-19 pandemic in the DRC is documented in the country from March 10, 2020, the date on which the first case was confirmed in the territory by the INRB. The DRC thus becomes the 11th African country affected by COVID-19. As of July 11, 2020, there are a total of 7,122 cases of COVID-19 infection, with 175 deaths and 1,785 recovered, bringing the number of active patients to 5162. As of the 11 of the same months, the cumulative cases increases to 7,905 cases, 189 deaths and 3,513 cured. Although very far from South Africa (250,687 cases), this number of infected places the DRC in 10th position (out of 57) among the most infected countries in Africa. Despite the efforts made so far in this country, it should be noted that there is still a long way to go to contain this pandemic and limit its spread, particularly in compliance with the barrier measures published by the authorities in the name of the population [<xref ref-type="bibr" rid="scirp.118742-ref5">5</xref>].</p><p>The COVID-19 pandemic is a global public health crisis. The stakes involved in the development of a vaccine are economic rather than political. Overall, 20% of those infected develop a severe or critical form of the disease, with a crude case fatality rate currently above 3%, which increases in the elderly and in those with certain underlying pathologies [<xref ref-type="bibr" rid="scirp.118742-ref6">6</xref>].</p><p>The spread of COVID-19 in the world is a real health shock in that, since its occurrence, it has significantly affected morbidity and mortality rates as well as the capacities of national health systems, even in advanced countries, to take good care for patients. On March 31, 2020, the number of infected people worldwide was estimated at 735,560, with a fatality rate of 4.76%. This figure changes very quickly over time. In the space of a month, as of April 30, 2020, the number of people infected with COVID-19 worldwide has increased to 3.33 million, a 4.53-fold increase with a fatality rate of 7% [<xref ref-type="bibr" rid="scirp.118742-ref7">7</xref>].</p><p>Vaccination in general has been considered the most life-saving intervention for a century and has gradually established itself as the best solution against infectious diseases. Vaccine hesitancy is ipso facto considered one of the ten greatest health threats by the WHO. In March 2020, 10 days after the first confinement, nearly 25% of the 5108 French people questioned, representatives of the general population, declared that they would probably or certainly refuse the vaccines against COVID-19 if it existed [<xref ref-type="bibr" rid="scirp.118742-ref1">1</xref>].</p></sec><sec id="s2"><title>2. Methodology</title><p>We conducted a cross-sectional study on the campus of the university residences of the University of Lubumbashi in the Democratic Republic of the Congo in the province of Haut-Katanga, city of Lubumbashi from 01/01/2021 to 30/06/2021. Our study is descriptive cross-sectional, and the study population consists of students residing in university residences.</p><sec id="s2_1"><title>2.1. Study Population and Sampling</title><p>Our study population consisted of student living on the University of Lubumbashi campus.</p><p>Regularly registered students who are housed in one of two homes during our study period were included in our study, while all non-regularly registered students as well as those regularly registered and staying in one of the homes outside from our study were excluded from our study.</p><p>Our sampling is probabilistic at two stages: The first stage allowed us to identify the different homes that were considered as clusters. Of these homes, we have chosen two, one of which houses the girls (Wards 2) and the other the boys (Wards 10). The second stage consisted in choosing in a simple random way at the rate of 50% in each cluster after drawing up two sampling frames for the two clusters.</p><p>Regarding the sample size, as it was said in the sampling, we took 50% in each cluster. Home 2 accommodates 192 female students and Home 10 accommodates 193 students. The size is donations: 193 students.</p></sec><sec id="s2_2"><title>2.2. Data Collection</title><p>The data of our study were collected on a form and encoded with Excel, analyzed with the software Epi info version 7.2.0.1 to be analyzed.</p></sec></sec><sec id="s3"><title>3. Results</title><p>From <xref ref-type="fig" rid="fig1">Figure 1</xref>, we notice that 95% or 49.22% of the students were of the Pentecostal religion.</p><p>As shown in <xref ref-type="table" rid="table1">Table 1</xref>, the average age is 23.3 years with a male predominance (50.3%).</p><p>As shown in <xref ref-type="table" rid="table2">Table 2</xref>, in 65.28% of cases, students were not ready to be vaccinated against 67% or 34.72%; One hundred and twenty-nine (129) students said that they always respect the barrier measures (gestures).</p><p>As shown in <xref ref-type="table" rid="table3">Table 3</xref>, there is a link between the acceptability of the vaccine and the post-injection manifestations as well as confidence in the vaccine (P = 0.00).</p><p>As shown in <xref ref-type="table" rid="table4">Table 4</xref>, confidence in the vaccine depends on post injection manifestations (P = 0.00).</p><p>As shown in <xref ref-type="table" rid="table5">Table 5</xref>, the obligatory nature of the vaccine depends on the confidence in the vaccine (P = 0.0003).</p><p>As shown in <xref ref-type="table" rid="table6">Table 6</xref>, knowledge of the importance of the vaccine depends on confidence in the vaccine as well as post-injection manifestations (P &lt; 0.05).</p><p>As shown in <xref ref-type="table" rid="table7">Table 7</xref>, compliance with barrier measures has no connection with gender, level of education or age (P &gt; 0.05).</p></sec><sec id="s4"><title>4. Discussion</title><p><xref ref-type="fig" rid="fig1">Figure 1</xref> indicates that 95% or 49.22% of the students were of the Pentecostal religion.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Sociodemographic characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >percentage</th><th align="center" valign="middle" >Minimum</th><th align="center" valign="middle" >Maximum</th><th align="center" valign="middle" >Means (&#177;)</th></tr></thead><tr><td align="center" valign="middle" >Age(year)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >18 - 24</td><td align="center" valign="middle" >136</td><td align="center" valign="middle" >70.5</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >23.3 Years (&#177;2.57)</td></tr><tr><td align="center" valign="middle" >&gt;24</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >29.5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >193</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >96</td><td align="center" valign="middle" >49.7</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >97</td><td align="center" valign="middle" >50.3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >193</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of students according to knowledge, attitudes and practices on COVID-19</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency (%)</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Vaccine acceptability</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >126 (65.3)</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >67 (34.7)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Reasons for refusing to get vaccinated</td></tr><tr><td align="center" valign="middle" >Post-vaccination event</td><td align="center" valign="middle" >120 (95.2)</td></tr><tr><td align="center" valign="middle" >Lack of confidence in the vaccine</td><td align="center" valign="middle" >6 (4.8)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Knowledge of barrier gestures</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >6 (3.1)</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >187 (96.9)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Moment of Respect for barrier gestures</td></tr><tr><td align="center" valign="middle" >At the Faculty/School</td><td align="center" valign="middle" >64 (33.2)</td></tr><tr><td align="center" valign="middle" >Anytime</td><td align="center" valign="middle" >129 (66.8)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Source (Origine) of COVID-19</td></tr><tr><td align="center" valign="middle" >Witchcraft</td><td align="center" valign="middle" >54 (27.9)</td></tr><tr><td align="center" valign="middle" >Diseases of dirty hands</td><td align="center" valign="middle" >26 (13.5)</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >113 (58.5)</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Association between acceptability and other study variables</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >Vaccine acceptability</th><th align="center" valign="middle" ></th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Variables</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >PR</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Age</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >18 - 24</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >0.40</td></tr><tr><td align="center" valign="middle" >&gt;24</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Sexe</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >0.26</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Niveau d’&#233;tude</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Under graduat</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >0.96</td><td align="center" valign="middle" >0.41</td></tr><tr><td align="center" valign="middle" >Graduat</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="3"  >Post injection events</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >0.40</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >101</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Vaccine confidence</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >113</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >3.8</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Association between confidence in the vaccine and the other variables</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >Vaccine confidence</th><th align="center" valign="middle" ></th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Variables</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >PR</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >0.9</td><td align="center" valign="middle" >0.52</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Education level</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Under graduat</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >0.90</td><td align="center" valign="middle" >0.18</td></tr><tr><td align="center" valign="middle" >Graduat</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="3"  >Post-injection manifestation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >0.56</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Association between the obligatory nature of the vaccine and the other variables of the study</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="3"  >Compulsory nature of the vaccine</th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Variables</td><td align="center" valign="middle" >Non</td><td align="center" valign="middle" >Oui</td><td align="center" valign="middle" >PR</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Niveau d’&#233;tude</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Under graduat</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >1.07</td><td align="center" valign="middle" >0.47</td></tr><tr><td align="center" valign="middle" >Graduat</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Confiance au vaccin</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >114</td><td align="center" valign="middle" >0.38</td><td align="center" valign="middle" >0.0003</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Association between knowledge of vaccine importance and study variables</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="4"  >Knowledge of the importance of the vaccine</th></tr></thead><tr><td align="center" valign="middle" >Variables</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >PR</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >1.2</td><td align="center" valign="middle" >0.17</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Education level</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Under graduat</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >0.88</td><td align="center" valign="middle" >0.29</td></tr><tr><td align="center" valign="middle" >Graduat</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="3"  >Post-injection manifestation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >0.55</td><td align="center" valign="middle" >0.0002</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Vaccine confidence</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >10.71</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Association between compliance with barrier measures and study variables</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="3"  >Respect for barrier measures</th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Variables</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >PR</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >0.9</td><td align="center" valign="middle" >0.65</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Study level</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Under graduat</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >96</td><td align="center" valign="middle" >1.86</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >Graduat</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >91</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >18 - 24</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >131</td><td align="center" valign="middle" >2.1</td><td align="center" valign="middle" >0.43</td></tr><tr><td align="center" valign="middle" >&gt;24</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p><xref ref-type="table" rid="table1">Table 1</xref> indicates that there were more students whose age is between 18 and 24 years old with an average age of 23.3 years old, a minimum age of 18 years old and a maximum age of 30 years old. This result can be explained by the fact that the age between 18 and 24 represents the age group of most Congolese students. These observations have also been made in Algeria [<xref ref-type="bibr" rid="scirp.118742-ref8">8</xref>].</p><p>We observed a large proportion of male students 97 (50.3%) (<xref ref-type="table" rid="table3">Table 3</xref>). Our results are different from those of a study conducted at the Higher Institute of Medical Techniques of Lubumbashi which reveals that most respondents were under the age of 25 (49.2%); the mean age was 26.4 &#177; 6.5 years. Female students were more observed (75.2%) [<xref ref-type="bibr" rid="scirp.118742-ref9">9</xref>]. On the other hand, some studies have found that women were in the majority [<xref ref-type="bibr" rid="scirp.118742-ref8">8</xref>].</p><p>According to <xref ref-type="table" rid="table2">Table 2</xref>, most students (65.3%) do not agree to be vaccinated and post-injection manifestations represent the large proportion of refusal to be vaccinated. Vaccine acceptability has a significant relationship with post-injection manifestations (<xref ref-type="table" rid="table4">Table 4</xref>). Our results are different from the study of medical students at a single allopathic medical school in Southeast Michigan which found that nearly all participants had positive attitudes toward vaccines; however, only 53% indicated they would participate in a COVID-19 vaccine trial and 23% were unwilling to take a COVID-19 vaccine [<xref ref-type="bibr" rid="scirp.118742-ref10">10</xref>]. Arati and the other authors found the same results in a study conducted on medical and dental students [<xref ref-type="bibr" rid="scirp.118742-ref11">11</xref>]. In Morocco, among health science students in Morocco, 26.9% of participants said they were willing to receive the vaccine against COVID-19 [<xref ref-type="bibr" rid="scirp.118742-ref12">12</xref>]. In Italy, Barello et al., found that 86.1% of students would choose to be vaccinated against the COVID-19 coronavirus compared to 13.9% who would not [<xref ref-type="bibr" rid="scirp.118742-ref13">13</xref>].</p><p>The post-injection manifestations as well as the confidence in the vaccine are the basis of the refusal to be vaccinated (P = 0.00). Confidence in the vaccine is influenced by post-injection manifestations (P = 0.00). Our results are similar to those found by Lucia et al. who found that fear of serious side effects was independently predictive of a lower likelihood of intention to participate in a COVID-19 vaccine trial (AOR = 0.41, P = 0.01) [<xref ref-type="bibr" rid="scirp.118742-ref10">10</xref>]. In the United States, according to a theory-based analysis (multi-theory model: MTM), behavioural trust (b = 0.089, p &lt; 0.001), participatory dialogue (b = 0.056, p &lt; 0.001) and changes in the Physical environment (b = 0.066, p = 0.001) were significantly associated with acceptance of the COVID-19 vaccine among those who were not hesitant to take the vaccine and accounted for 54.8% of the variance. Of those who were hesitant to take the COVID-19 vaccine, the MTM construct of behavioural trust (b = 0.022, p &lt; 0.001) was significant with political affiliation to the Republican Party (b = −0.464, p = 0.004), which was negatively associated with vaccine acceptance [<xref ref-type="bibr" rid="scirp.118742-ref14">14</xref>]. In Egypt, the most confirmed barriers to vaccination against COVID-19 were insufficient data regarding the adverse effects of the vaccine (potential 74.17% and unknown 56.31%) and insufficient information regarding the vaccine itself (72.76%) [<xref ref-type="bibr" rid="scirp.118742-ref15">15</xref>]. In Italy, the most common reasons given for refusing the vaccine were: being against vaccines in general, safety concerns/thinking that a hastily produced vaccine is too dangerous, seeing the vaccine as unnecessary due to the harmless nature of COVID-19, general lack of trust, doubts about the effectiveness of the vaccine, belief of being already immune, doubt about the provenance of the vaccine [<xref ref-type="bibr" rid="scirp.118742-ref16">16</xref>].</p><p>Regarding the time indicated to respect the barrier measures (rules), 66.8% of students always observe them while 33.2% only respect them at their faculty or school (<xref ref-type="table" rid="table2">Table 2</xref>). Compliance with the barrier measures against the “COVID-19” coronavirus in the premises of the Faculty of Medicine of Sousse was an obligation for all students. Failure to comply with this measure may be subject to disciplinary action for breach of article 18 of the internal regulations “Student behaviour” [<xref ref-type="bibr" rid="scirp.118742-ref17">17</xref>]. In addition, Ngoyi in his study conducted in Lubumbashi indicates that 82.9% of students do not respect the barrier measures [<xref ref-type="bibr" rid="scirp.118742-ref9">9</xref>].</p><p>Regarding knowledge of the source of COVID-19, <xref ref-type="table" rid="table2">Table 2</xref> shows that bad luck was cited in 27.9% of cases, the disease of dirty hands diseases (13.5%) while most students cited other causes (58.5%).</p><p>People who do not trust the vaccine do not advocate for the compulsory nature of the vaccine against COVID-19 (<xref ref-type="table" rid="table5">Table 5</xref>) and the compulsory nature of the vaccine depends on the trust in the vaccine (P = 0.0003). In France, the Ministry of Solidarity and Public Health as well as the Ministry of Higher Education, Research and Innovation had instructed the implementation of the vaccination obligation for students and pupils in Health [<xref ref-type="bibr" rid="scirp.118742-ref18">18</xref>].</p><p>Concerning the Knowledge of the importance of the vaccine, <xref ref-type="table" rid="table6">Table 6</xref> shows a significant link with confidence in the vaccine (P = 0.00), and post-injection manifestations (P = 0.0002).</p><p>Knowledge of the importance of the vaccine depends on confidence in the vaccine as well as post-injection manifestations (P &lt; 0.05) (<xref ref-type="table" rid="table6">Table 6</xref>).</p><p>In our study, we found no link between compliance with barrier measures and gender, level of education and age (P &gt; 0.05) as shown in <xref ref-type="table" rid="table7">Table 7</xref>.</p></sec><sec id="s5"><title>5. Conclusion</title><p>We conducted a cross-sectional study on the acceptability of the COVID-19 vaccine in the university residences of the University of Lubumbashi. In 49.22% of cases, the students were of the Pentecostal religion with an average age of 23.3 years old. Most students (65.3%) do not agree to be vaccinated and post-injection manifestations represent a large proportion of refusal to be vaccinated. Vaccine acceptability has a significant relationship with post-injection manifestations. It is important that good awareness of vaccination is done to make the vaccine against COVID-19 acceptable among students.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="s7"><title>Cite this paper</title><p>Bute, M.B.M., Lugoma, C.K., Mupanda, Y.M., Watanga, V.B.N., Djino, M.U., Mulaji, P.K., Nkomba, E.K., Cl&#233;ment, U.T., Lukanda, J.-L.B., Yemba, F.L., Umba, F.K., Amisa, L.F., Ntamwenge, C.M., Nyandwe, A.K., Kasongo, N.M., Kabeya, B., Kwambamba, J.C.M., Benjamin, K.I. and Kandolo, S.I. (2022) Knowledge Attitudes and Practices of Students Regarding the Vaccine against Covid19. Case of Students Living on the University Campuses of the University of Lubumbashi. Open Access Library Journal, 9: e8996. https://doi.org/10.4236/oalib.1108996</p></sec></body><back><ref-list><title>References</title><ref id="scirp.118742-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Université de Sousse (2020) Note aux étudiants pour le respect des mesures d’hygiène et de prévention du ‘Coronavirus-Covid/19’. Note aux étudiants pour le respect des mesures d’hygiène et de prévention du ‘Coronavirus-Covid/19’ Tout.</mixed-citation></ref><ref id="scirp.118742-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Troiano, G. and Nardi, A. (2021) Vaccine hesitancy in the era of COVID-19. The Royal Society for Public Health, 194, 1-8.</mixed-citation></ref><ref id="scirp.118742-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Saied, S.M., Saied, E.M., Kabbash, I.A. and Abdo, S.A.E.F. (2021) Vaccine Hesitancy: Beliefs and Barriers Associated with COVID-19 Vaccination among Egyptian Medical Students. Journal of Medical Virology, 93, 4280-4291.  
https://doi.org/10.1002/jmv.26910</mixed-citation></ref><ref id="scirp.118742-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, M., Davis, R.E. and Wilkerson, A.H. (2021) Covid-19 Vaccine Acceptance among College Students: A Theory-Based Analysis. International Journal of Environmental Research and Public Health, 8, Article 4617.  
https://doi.org/10.3390/ijerph18094617</mixed-citation></ref><ref id="scirp.118742-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Barello, S., Nania, T., Dellafiore, F., Graffigna, G. and Caruso, R. (2020) ‘Vaccine Hesitancy’ among University Students in Italy during the COVID-19 Pandemic. European Journal of Epidemiology, 35, 781-783.  
https://doi.org/10.1007/s10654-020-00670-z</mixed-citation></ref><ref id="scirp.118742-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Khalis, M., Boucham, M., Luo, A., Marfak, A., Saad, S., et al. (2021) Covid-19 Vaccination Acceptance among Health Science Students in Morocco: A Cross-Sectional Study. Vaccines, 9, 1-10. https://doi.org/10.3390/vaccines9121451</mixed-citation></ref><ref id="scirp.118742-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kelekar, A., Lucia, V.C., Afonso, N.M. and Ana, K. (2020) COVID-19 Vaccine Acceptance and Hesitancy among Dental and Medical Students. Journal of Chemical Information and Modeling, 21, 1-9.</mixed-citation></ref><ref id="scirp.118742-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Lucia, V.C., Kelekar, A. and Afonso, N.M. (2021) COVID-19 Vaccine Hesitancy among Medical Students. Journal of Public Health (United Kingdom), 43, 445-449.  
https://doi.org/10.1093/pubmed/fdaa230</mixed-citation></ref><ref id="scirp.118742-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ngoyi, J.M., Kabamba, L.N., Tambwe, P.N., et al. (2020) Connaissances, attitudes et pratiques liées au SRAS-COV-2 (COVID-19) chez les étudiants de l’Institut Supérieur des Techniques Médicales de Lubumbashi. Revue de l'Infirmier Congolais, 2, 7-10.</mixed-citation></ref><ref id="scirp.118742-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Mehda, O. (2021) Connaissances, attitudes et pratiques à l’égard de COVID-19 chez les étudiants de l’université. Université Mohamed El Bachir El Ibrahimi B.B.A.</mixed-citation></ref><ref id="scirp.118742-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">OMS (2020) Plan national de déploiement et de vaccination applicable aux vaccins contre la COVID-19 Présentation du document d’orientation sur le plan national de vaccination et de déploiement applicable aux vaccins contre la COVID-19.</mixed-citation></ref><ref id="scirp.118742-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">UNESCO (2020) Incidences socio-économiques et culturelles du covid-19 sur l’Afrique réponses de l’unesco.</mixed-citation></ref><ref id="scirp.118742-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">OMS (2020) RIPOSTE à LA COVID-19.</mixed-citation></ref><ref id="scirp.118742-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">UNICEF (2021) Guide de sensibilisation sur le coronavirus. 1-12.</mixed-citation></ref><ref id="scirp.118742-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Slovakia Public Health Authority (2021) COVID-19 in Slovakia. Analysis of Disease COVID-19 Based on Epidemiological Enquiry Realized by Regional Public Health Authorities from 1.9.2020 to 30.9.2020.  
https://covid-19.nczisk.sk/sk</mixed-citation></ref><ref id="scirp.118742-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Godlee, F. (2019) What Should We Do about Vaccine Hesitancy? BMJ, 365, 4044.  
https://doi.org/10.1136/bmj.l4044</mixed-citation></ref><ref id="scirp.118742-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Centers for Disease Control and Prevention (2020) Human Coronavirus Types.  
https://www.cdc.gov/coronavirus/types.html</mixed-citation></ref><ref id="scirp.118742-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Li, Y.D., Chi, W.Y., Su, J.H., Ferrall, L., Hung, C.F. and Wu, T.C. (2020) Coronavirus Vaccine Development: From SARS and MERS to COVID-19. Journal of Biomedical Science, 27, 1-23. https://doi.org/10.1186/s12929-020-00695-2</mixed-citation></ref></ref-list></back></article>